000			02313 a2200601 4500
005			20250516125644.0
264		0	_c20130917
008			201309s 0 0 eng d
022			_a1873-3913
024	7		_a10.1016/j.cellsig.2012.12.008 _2doi
040			_aNLM _beng _cNLM
100	1		_aFahmi, Ahmed
245	0	0	_ap42/p44-MAPK and PI3K are sufficient for IL-6 family cytokines/gp130 to signal to hypertrophy and survival in cardiomyocytes in the absence of JAK/STAT activation. _h[electronic resource]
260			_bCellular signalling _cApr 2013
300			_a898-909 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aCell Survival _xdrug effects
650	0	4	_aCells, Cultured
650	0	4	_aCytokine Receptor gp130 _xgenetics
650	0	4	_aFlavonoids _xpharmacology
650	0	4	_aHumans
650	0	4	_aHypertrophy
650	0	4	_aImidazoles _xpharmacology
650	0	4	_aInterleukin-6 _xgenetics
650	0	4	_aJanus Kinases _xmetabolism
650	0	4	_aLeukemia Inhibitory Factor _xgenetics
650	0	4	_aMice
650	0	4	_aMitogen-Activated Protein Kinase 1 _xantagonists & inhibitors
650	0	4	_aMitogen-Activated Protein Kinase 3 _xantagonists & inhibitors
650	0	4	_aMyocytes, Cardiac _xcytology
650	0	4	_aNitric Oxide _xmetabolism
650	0	4	_aNitric Oxide Synthase Type II _xmetabolism
650	0	4	_aPhosphatidylinositol 3-Kinases _xmetabolism
650	0	4	_aPhosphorylation
650	0	4	_aPyridines _xpharmacology
650	0	4	_aRats
650	0	4	_aReceptors, Erythropoietin _xgenetics
650	0	4	_aRecombinant Fusion Proteins _xgenetics
650	0	4	_aRecombinant Proteins _xbiosynthesis
650	0	4	_aReperfusion Injury _xmetabolism
650	0	4	_aSTAT1 Transcription Factor _xmetabolism
650	0	4	_aSTAT3 Transcription Factor _xantagonists & inhibitors
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_ap38 Mitogen-Activated Protein Kinases _xmetabolism
700	1		_aSmart, Nicola
700	1		_aPunn, Anu
700	1		_aJabr, Rita
700	1		_aMarber, Michael
700	1		_aHeads, Richard
773	0		_tCellular signalling _gvol. 25 _gno. 4 _gp. 898-909
856	4	0	_uhttps://doi.org/10.1016/j.cellsig.2012.12.008 _zAvailable from publisher's website
999			_c22372839 _d22372839